She has influenced major advances in her field including the description of key mutations and designing/leading global clinical trials, for example the first JAK inhibitor trial in Europe. Claire is the chief investigator for several other international and national clinical trials.
Claire has strong international collaborations in France, Germany, Spain and the USA amongst others. She contributes to British Society of Haematology and the European Haematology Association.
She has worked with enthusiastic patients to create a patient charity MPNvoice, and also works with other patient charities such as Blood Cancer UK and MPN research foundation.